Besides the ≥20% criterion are cases of core-binding factor (CBF)-AML, nucleophosmin 1 (NPM1)-mutated AML, or acute promyelocytic leukemia (APL); in each of them, the AML diagnosis is blast %-independent. The gene discussed is NPM1; the disease is acute promyelocytic leukemia.